Mylan NV (MYL.OQ)

Wed, Apr 25 2018

BRIEF-Mylan Adds To Growing Women's Healthcare Portfolio With Launch Of Generic For Oral Contraceptive Yaz

* MYLAN ADDS TO GROWING WOMEN'S HEALTHCARE PORTFOLIO WITH LAUNCH OF GENERIC FOR ORAL CONTRACEPTIVE YAZ®

EpiPen shortages seen in Canada, UK but U.S. supply intact

NEW YORK Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.

EpiPen shortages seen in Canada, UK but U.S. supply intact

NEW YORK, April 13 Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.

Deals of the day-Mergers and acquisitions

April 13 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Mylan seeks deal for German Merck's consumer products unit: sources

FRANKFURT/NEW YORK Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA's consumer health business after other bidders failed to meet the German company's price expectations, people familiar with the matter said.

UPDATE 2-Mylan seeks deal for German Merck's consumer products unit -sources

FRANKFURT/NEW YORK, April 13 Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA's consumer health business after other bidders failed to meet the German company's price expectations, people familiar with the matter said.

Mylan seeks deal for German Merck’s consumer products unit -sources

FRANKFURT/NEW YORK, April 13 Generic drug maker Mylan is in advanced discussions to acquire Merck KGaA’s consumer health unit after other bidders failed to meet the German company’s price expectations, people familiar with the matter said.